Related Experiment Video
Updated: May 20, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Haptoglobin is present in albumin used as a replacement solution for plasma exchange
Joan Cid1, Montserrat Elena, Fritz Diekmann
1Apheresis Unit, Department of Hemotherapy-Hemostasis, University de Barcelona, Barcelona, Spain. jcid@clinic.ub.es
Background:
Albumin is frequently used as replacement solution when performing plasma exchanges (PEs) and there are no previous data about the content of haptoglobin. The objective was to study the content of haptoglobin in albumin solution and the effect of PE on the removal of haptoglobin, a plasma protein often used for monitoring hemolytic conditions treated with PE.
Study Design And Methods:
Haptoglobin was measured in the 5% albumin replacement solution. It was also measured before and after performing 12 PEs using 5% albumin as a replacement solution on four patients. There were three patients with haptoglobin values within the reference range before starting PEs whereas one patient had low levels because of microangiopathic hemolytic anemia.
Results:
The mean content of haptoglobin in the 5% albumin replacement solution was 0.157±0.005g/L. Predicted removal according to the one-compartment model was 70% to 77%. Real removal (RR) of haptoglobin in patients with values within the reference range was 7% to 67%. The RR correlated with the value of haptoglobin before performing PE (r=0.709; r(2) =0.502; p=0.03). When haptoglobin levels were low before PE, the levels after the PE were those present in the albumin used as a replacement solution.
Conclusion:
Albumin solution used for PE contained haptoglobin and it explained in part the kinetics removal of plasma haptoglobin observed in the patients.
More Related Videos
11:31Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
09:47Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
Published on: June 14, 2024
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...